Optum Rx, a major pharmacy benefit manager (PBM) owned by UnitedHealth, announced on March 19, 2025, that it will eliminate prior authorization requirements for approximately 80 medications, according to BioPharma Dive. Starting May 1, Optum Rx will stop mandating reauthorization for certain drugs already prescribed to patients for chronic conditions like migraines, multiple sclerosis, lung disease, and high cholesterol. This initiative is expected to eliminate up to 25% of all reauthorization requests, equating to a 10% overall reduction in prior authorizations. ...
Managed Care
Advertisement
responding physicians (92%) reported that prior authorization causes treatment delays for their patients
the potential to narrow the gap in sleep apnea outcomes that exists between well-resourced communities and those that have lo
Black women experience more frequent delays through the breast cancer care continuum.
Dr. Sherri Onyiego of Equality Health discusses how value-based care improves healthcare access.
Simply adding more staff is not sufficient to bridge the gap in quality of care and health outcomes among nursing homes
Disparities in access to omalizumab for patients with CSU significantly impact treatment patterns and health outcomes.
Teresa McArthur, MS, RD, CDCES, on How Virtual Specialty Care Can Promote Health Equity
Alina Czekai, MPH, talks to Urban Health Today about Improving Patient Care Access through Enhanced Prior Authorization.
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.